Article open access publication

Oncohistones: drivers of pediatric cancers

Genes & Development, Cold Spring Harbor Laboratory, ISSN 0890-9369

Volume 31, 23-24, 2017

DOI:10.1101/gad.309013.117, Dimensions: pub.1100540825, PMC: PMC5795778, PMID: 29352018,

Affiliations

Organisations

  1. (1) University of Copenhagen, grid.5254.6, KU

Countries

Denmark

Continents

Europe

Description

One of the most striking results in the area of chromatin and cancer in recent years has been the identification of recurrent mutations in histone genes in pediatric cancers. These mutations occur at high frequency and lead to the expression of mutant histones that exhibit oncogenic features. Thus, they are termed oncohistones. Thus far, mutations have been found in the genes encoding histone H3 and its variants. The expression of the oncohistones affects the global chromatin landscape through mechanisms that have just begun to be unraveled. In this review, we provide an overview of histone mutations that have been identified and discuss the possible mechanisms by which they contribute to tumor development. We further discuss the targeted therapies that have been proposed to treat cancers expressing oncohistones.

Funders

Funders and Grants

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Copenhagen

Dimensions Citation Indicators

Times Cited: 29

Field Citation Ratio (FCR): 9.08

Relative Citation ratio (RCR): 1.51

Open Access Info

Hybrid